Heart-calming and nerve-soothing composition for assisting heart disease treatment and preparation method of heart-calming and nerve-soothing composition
By using a specific composition of calming and soothing ingredients, combined with nano-essential oil emulsions and traditional Chinese medicine extracts, the problem of insufficient improvement in psychological state during the treatment of heart disease is solved. It achieves a continuous release and absorption mechanism, significantly relieves anxiety, improves sleep and cardiac function, and enhances treatment adherence.
Patent Information
- Application Number
- CN202411162838.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-23
- Publication Date
- 2024-11-26
AI Technical Summary
Existing treatments for heart disease are insufficient in improving patients' mental state and quality of life. Emotional problems such as anxiety and insomnia affect treatment adherence and may exacerbate heart disease. There is a lack of effective combination therapy for calming the mind and soothing the nerves.
A calming and sedative composition for the adjunctive treatment of heart disease is employed, comprising a specific ratio of drug layer, modified hydroxypropyl methylcellulose, polyurethane, polyethylene, polymethyl methacrylate, glycerin, and a penetration enhancer. Transdermal absorption is enhanced through a nano-essential oil emulsion, and combined with extracts of traditional Chinese medicine ingredients such as cypress seed, jujube seed, polygala root, and acorus tatarinowii, utilizing their pharmacological effects to regulate the nervous system and cardiac function.
It significantly enhances the overall therapeutic effect of calming the mind and soothing the nerves, relieves anxiety through sustained release and absorption mechanisms, improves sleep quality, regulates cardiac function, improves treatment adherence, reduces adverse reactions, enhances cardiac blood supply and memory, and forms a stable patch matrix suitable for long-term use.
Smart Images

Figure CN119015367A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of bioengineering pharmaceuticals, and specifically relates to a tranquilizing and calming composition for assisting the treatment of heart disease and a preparation method thereof. Background Art
[0002] Heart disease is one of the major fatal diseases worldwide, and its main types include coronary heart disease, heart failure, arrhythmia and hypertensive heart disease. These diseases usually lead to insufficient blood supply to the heart, myocardial damage, and even heart failure, which seriously threatens the life safety and quality of life of patients. With the advancement of medical technology, the treatment of heart disease has made significant progress, but it still faces many challenges. Traditional treatment methods include drug therapy, interventional therapy and surgical treatment, each of which has its unique role in improving patient prognosis and reducing complications. In the treatment of heart disease, although drug therapy and surgical intervention have achieved remarkable results in controlling the disease, the patient's mental health and quality of life are still facing challenges. Emotional problems such as anxiety, insomnia, and depression not only affect the patient's treatment compliance, but also may increase the risk of worsening heart disease. Therefore, how to regulate the patient's psychological state while stabilizing the symptoms of heart disease has become an important topic of treatment. In view of the symptoms of anxiety, insomnia, palpitations, etc. that are often accompanied by heart disease patients, it is very necessary to use a composition with a calming effect as an auxiliary treatment. The calming ingredients can relieve the anxiety and tension caused by the disease in patients, improve sleep quality, and thus indirectly improve the treatment effect of heart disease. By adjusting the patient's mental state, the adverse reactions caused by long-term use of heart disease drugs can be reduced. The improvement of the mental state can improve the patient's compliance with treatment and ensure that the drugs are taken on time and in the right amount. Therefore, based on the above problems, it is extremely necessary to develop a tranquilizing and calming composition that can effectively improve the patient's mental state and relieve anxiety to assist in the treatment of heart disease. Summary of the invention
[0003] In view of the defects of the prior art, the object of the present invention is to provide a tranquilizing and soothing composition for assisting the treatment of heart disease and a preparation method thereof.
[0004] The technical effect described in the present invention is achieved through the following technical scheme: a calming and tranquilizing composition for assisting the treatment of heart disease, comprising the following raw materials in parts by weight: 40 to 60 parts of a drug layer, 25 to 35 parts of polyurethane, 35 to 50 parts of modified hydroxypropyl methylcellulose, 20 to 35 parts of polyethylene, 15 to 25 parts of polymethacrylate, 5 to 10 parts of glycerol and 7 to 12 parts of a penetration enhancer.
[0005] Preferably, the composition of the drug layer includes the following raw materials in parts by weight: 12-15 parts of Platycladus orientalis seed extract, 18-25 parts of Ziziphus jujuba seed extract, 4-10 parts of Polygala tenuifolia extract, 6-10 parts of Acorus calamus extract and 15-20 parts of Chinese herbal medicine extract.
[0006] Preferably, the composition of the Chinese medicine extract includes the following raw materials in parts by weight: 10-15 parts of Schisandra chinensis, 15-20 parts of Ziziphus jujuba seeds, 10-15 parts of white peony roots, 10-15 parts of Angelica sinensis, 5-10 parts of Gardenia jasminoides, 10-15 parts of Pinellia ternata, 15-20 parts of Nelumbo nucifera, 5-10 parts of Licorice, 5-10 parts of Poria cocos, 3-5 parts of Atractylodes macrocephala and 15-20 parts of Ophiopogon japonicus.
[0007] Preferably, the Chinese herbal medicine extract is prepared by water decoction using water as solvent.
[0008] Preferably, the cypress seed extract is prepared by ethanol reflux extraction using 80 wt % ethanol as solvent.
[0009] Preferably, the spinosa jujube seed extract is prepared by ethanol reflux extraction using 40 wt % ethanol as solvent.
[0010] Preferably, the Polygala tenuifolia extract is prepared by water decoction using water as solvent.
[0011] Preferably, the Acorus calamus extract is prepared by steam distillation using water as solvent.
[0012] Preferably, the preparation steps of the modified hydroxypropyl methylcellulose are as follows: I: Add hydroxypropyl methylcellulose to anhydrous dichloromethane, heat in a water bath to 50-60°C, stir and dissolve evenly to obtain a 5-10wt% hydroxypropyl methylcellulose solution; II: adding hexadecyltrimethoxysilane to the hydroxypropyl methylcellulose solution prepared in step I, stirring continuously and heating to 80-100° C. at a rate of 2-5° C. / min. After heating, adding p-toluenesulfonic acid, maintaining the temperature, stirring and reacting for 4-8 hours, and cooling to room temperature to obtain a mixed solution; III: Add 10 wt% sodium bicarbonate solution to the mixed solution prepared in step II, let stand to separate the layers, remove the upper organic phase, dry with anhydrous sodium sulfate, then filter to remove the anhydrous sodium sulfate, wash with ethanol, and dry under vacuum at 50° C. to constant weight to obtain modified hydroxypropyl methylcellulose.
[0013] Preferably, in step II, the ratio of the amount of hexadecyltrimethoxysilane to hydroxypropylmethylcellulose is 0.8-1.5 mL:1 g; and the ratio of the amount of p-toluenesulfonic acid to hexadecyltrimethoxysilane is 0.005-0.01 g:1 mL.
[0014] Preferably, the ratio of the sodium bicarbonate solution to the p-toluenesulfonic acid in step III is 13-18 mL: 1 g.
[0015] Preferably, the penetration enhancer is a nano essential oil emulsion, and the specific preparation steps are as follows: (1): lavender oil, thyme oil, ylang-ylang oil and sweet almond oil are mixed in a volume ratio of 1:1:1:2, 3-5 wt% of Tween-80 and 2-5 wt% of propylene glycol are added, the temperature is controlled at 35° C. in a water bath, and the mixture is stirred at 300-500 rpm for 30-50 min to obtain an oil phase; (2): adding anhydrous ethanol to deionized water, stirring and mixing to obtain an aqueous phase; pouring the oil phase prepared in step (1) into the aqueous phase continuously and slowly during the stirring process, stirring at a speed of 10000 to 15000 rpm for emulsification reaction for 10 to 15 minutes, and after the emulsification is completed, ultrasonic treatment is performed at 200 to 400 W for 5 to 10 minutes to obtain a nanoemulsion; (3): The nanoemulsion prepared in step (2) is placed at 4° C. for 12 h, subjected to refrigerated centrifugation at 3000 rpm for 10 min, and filtered through a 0.22 μm filter membrane to obtain a nano-essential oil emulsion.
[0016] Preferably, the lavender oil, thyme oil and ylang-ylang oil in step (1) are prepared by steam distillation; and the sweet almond oil is prepared by cold pressing.
[0017] Preferably, the amount of anhydrous ethanol in step (2) is 10-15% of the volume of deionized water, and the amount of water phase is 3-5 times the volume of the oil phase.
[0018] Preferably, the emulsification stirring operation and the ultrasonic treatment operation in step (2) are both performed in an ice bath.
[0019] Preferably, another aspect of the present invention is to provide a method for preparing a tranquilizing and calming composition for assisting the treatment of heart disease, and the specific preparation steps are as follows: S1: Disperse modified hydroxypropyl methylcellulose in 15 parts by weight of deionized water, heat in a water bath to 60-70°C, and stir to dissolve uniformly to obtain a modified hydroxypropyl methylcellulose solution; melt polyurethane at 80°C, then add it to the modified hydroxypropyl methylcellulose solution, stir and mix uniformly, then melt polyethylene at 80-90°C and add it, continue to stir and mix uniformly to obtain a mixed solution; S2: dissolving polymethacrylate into 10 times the weight of 60wt% ethanol solution, stirring and mixing to obtain a polymethacrylate solution; adding the polymethacrylate solution to the mixed solution prepared in step 1, heating to 60°C in a water bath, stirring for 30 minutes, and mixing evenly, adding the nano essential oil emulsion, maintaining the temperature at 40°C, stirring and mixing evenly, and pouring it into a mold, with a thickness parameter of 0.1-0.3mm, drying at room temperature for 2-4h, raising the temperature to 35-45°C, and drying for 12-24h to obtain a matrix layer; S3: adding the Platycladus orientalis seed extract, Ziziphus jujuba seed extract, Polygala tenuifolia extract, Acorus calamus extract and the Chinese herbal medicine extract in the drug layer to 8 parts by weight of a 70 wt % ethanol solution, stirring and dissolving the mixture uniformly to obtain an extract solution; S4: Scrape the extract solution prepared in step 3 onto the matrix layer prepared in step 2, with each scraping thickness of 20 to 50 μm, and scrape for 3 times. After each scraping, dry at a temperature of 30 to 40°C for 10 minutes. After all the scraping is completed, dry at 40°C for 60 minutes to obtain a tranquilizing and calming composition.
[0020] The beneficial effects of the present invention are as follows: The present invention utilizes flavonoids in Semen Ziziphi Spinosae to enhance the activity of γ-aminobutyric acid (GABA) receptors in the central nervous system to exert a sedative effect; the volatile oil components in Semen Platycladi in the patch extend the action time of Semen Ziziphi Spinosae flavonoids through a sustained release mechanism, and at the same time, the fatty oil components in Semen Platycladi contribute to the uniform release and continuous absorption in the patch, so that the fat-soluble components of Semen Ziziphi Spinosae can more efficiently penetrate the skin barrier; the two are combined in the patch, and the overall therapeutic effect of tranquilizing the mind and calming the nerves is significantly enhanced through continuous release and absorption. The saponin compounds in Polygala Tenuifolia improve memory and cognitive function by promoting the release of acetylcholine and improving the efficiency of neurotransmission. In the patch, the volatile oil components in Acorus calamus enhance the permeability of the skin locally, promote the passage of Polygala tenuifolia saponins through the skin and act more effectively on the central nervous system. In addition, the sustained release of the volatile oil of Acorus calamus in the patch helps prevent the degradation of Polygala tenuifolia saponins before contacting the skin, ensuring that they can penetrate and function more stably during the use of the patch; the combination of the two enhances the overall effect of tranquilizing the mind and improving intelligence and calming the mind by enhancing penetration and prolonging the action time in the patch. By introducing hydrophobic groups (long-chain alkyl groups) into hydroxypropyl methylcellulose (HPMC), its hydrophobicity is significantly enhanced, and it interacts with fat-soluble extracts and essential oil components, which can better coat and disperse these fat-soluble components to form a stable patch matrix, preventing the drug from precipitating in the patch due to poor compatibility. The introduction of hydrophobic groups can improve the mechanical properties of hydroxypropyl methylcellulose, so that it forms a more stable composite material with hydrophobic polymers polyurethane and polyethylene, giving the patch better waterproofness and durability, suitable for long-term use.
[0021] The present invention uses Schisandra chinensis as the main drug to mainly regulate heart function, enhance the excitability and inhibition of the heart, and regulate blood pressure; Chinese date seeds, white peony root, lotus seeds, Poria cocos and other medicinal materials are used as ministerial drugs and adjuvant drugs to further calm the mind and stabilize the heart, and enhance the regulatory function of the heart; Chinese angelica, Gardenia jasminoides and other medicinal materials for promoting blood circulation and removing blood stasis improve blood circulation and reduce the burden on the heart, while Pinellia ternata helps to remove phlegm and dampness and reduce heart discomfort caused by phlegm and dampness blockage; Licorice and Atractylodes macrocephala play the role of invigorating qi and strengthening the spleen, invigorating qi and calming the heart, and supporting the overall function of the heart; these medicinal materials work together through different mechanisms to enhance heart function, relieve symptoms such as palpitations and insomnia, regulate blood pressure, improve heart blood supply, and form a complete auxiliary treatment preparation for heart disease.
[0022] The composition of the present invention mainly uses a patch as the main application form, and uses a nano-essential oil emulsion as a penetration enhancer to promote the active ingredient to enter the human skin and play a role. The linalyl acetate in lavender oil, the thymol in thyme oil, the methyl benzoate in ylang-ylang oil and the oleic acid in sweet almond oil work together to enhance the transdermal absorption effect; linalyl acetate and thymol dissolve the lipid layer of the skin to reduce the barrier function of the stratum corneum, and oleic acid, as an unsaturated fatty acid, can be inserted into the lipid bilayer of the skin cell membrane, increase the fluidity of the membrane, and make it easier for fat-soluble drug components to penetrate. The linoleic acid in sweet almond oil can not only maintain the moisture of the skin, but also repair the dry skin problem that may be caused by these essential oil components dissolving the lipid layer. Linoleic acid reduces skin irritation through its moisturizing and anti-inflammatory effects, and prolongs the active time of the drug on the skin. Hydrophobic modified hydroxypropyl methylcellulose can better interact with the lipid layer of the skin, reduce the barrier function of the stratum corneum, promote the transdermal absorption of fat-soluble drugs and essential oil components, increase the solubility of active ingredients in the skin lipid bilayer, and enhance its diffusion rate. The present invention utilizes the low surface tension of nanoemulsion to promote the essential oil to diffuse better to the skin surface, increase the contact area with the skin, and further promote the transdermal absorption of active ingredients; considering that essential oil may irritate the skin at high concentrations, through nanoemulsion technology, the essential oil components can be released more evenly and at a uniform rate, avoiding skin irritation caused by high local concentrations. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] In order to more clearly illustrate the technical solutions in the present invention or the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings in the following description are only for the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0024] Figure 1It is a permeability test diagram of the tranquilizing and analgesic compositions prepared in Examples 2 to 3 of the present invention and Comparative Examples 1 to 3; Figure 2 It is a test chart of promoting sleep in mice of the tranquilizing and analgesic compositions prepared in Examples 1 to 4 and Comparative Examples 1 to 3 of the present invention. DETAILED DESCRIPTION
[0025] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them; based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention. It should be noted that, unless otherwise specified, the raw materials involved in the present invention are purchased through conventional commercial channels.
[0026] Example 1: A tranquilizing and calming composition for assisting the treatment of heart disease, comprising the following raw materials in parts by weight: 40 parts of a drug layer, 25 parts of polyurethane, 35 parts of modified hydroxypropyl methylcellulose, 20 parts of polyethylene, 15 parts of polymethacrylate, 5 parts of glycerol, and 7 parts of a penetration enhancer; The drug layer composition includes the following raw materials by weight: 12 parts of Platycladus orientalis seed extract, 18 parts of Ziziphus jujuba seed extract, 4 parts of Polygala tenuifolia extract, 6 parts of Acorus calamus extract and 15 parts of Chinese herbal medicine extract; The composition of the Chinese medicine extract includes the following raw materials by weight: 10 parts of Schisandra chinensis, 15 parts of Ziziphus jujuba seeds, 10 parts of white peony root, 10 parts of Angelica sinensis, 5 parts of Gardenia jasminoides, 10 parts of Pinellia tuber, 15 parts of Lotus pith, 5 parts of Licorice, 5 parts of Poria cocos, 3 parts of Atractylodes macrocephala and 15 parts of Ophiopogon japonicus.
[0027] The specific preparation steps of the tranquilizing and calming composition for assisting the treatment of heart disease are as follows: S1: The cypress seed extract is prepared by ethanol reflux extraction using 80 wt % ethanol as solvent; S2: the spinosa jujube seed extract is prepared by ethanol reflux extraction using 40 wt % ethanol as solvent; S3: The polygala root extract is prepared by a water decoction method using water as a solvent; S4: The Acorus calamus extract is prepared by steam distillation using water as solvent; S5: The Chinese herbal medicine extract is prepared by water decoction using water as solvent; S6: The preparation steps of the modified hydroxypropyl methylcellulose are as follows: I: Add hydroxypropyl methylcellulose to anhydrous dichloromethane, heat in a water bath to 50°C, stir and dissolve evenly to obtain a 5wt% hydroxypropyl methylcellulose solution; II: Add 16 mL of hexadecyltrimethoxysilane to 400 mL of hydroxypropyl methylcellulose solution prepared in step I, continue stirring and heat to 80°C at a rate of 2°C / min. After heating, add 0.08 g of p-toluenesulfonic acid, maintain the temperature, stir and react for 8 hours, and cool to room temperature to obtain a mixed solution; III: Add 1.04 mL of 10 wt% sodium bicarbonate solution to the mixed solution prepared in step II, let stand for stratification, remove the upper organic phase, dry with anhydrous sodium sulfate, then filter to remove anhydrous sodium sulfate, wash with ethanol, and dry under vacuum at 50° C. to constant weight to obtain modified hydroxypropyl methylcellulose; S7: The penetration enhancer is a nano essential oil emulsion, and the specific preparation steps are as follows: (1): 20 mL of lavender oil, 20 mL of thyme oil, 20 mL of ylang-ylang oil and 40 mL of sweet almond oil were mixed, 2 g of Tween-80 and 2 mL of propylene glycol were added, the mixture was heated in a water bath to control the temperature at 35°C, and stirred at 300 rpm for 50 min to obtain an oil phase; (2): 50 mL of anhydrous ethanol was added to 500 mL of deionized water, and the mixture was stirred to obtain an aqueous phase; 100 mL of the oil phase prepared in step (1) was slowly poured into 300 mL of the aqueous phase during the stirring process, and the treatment operation was carried out in an ice bath, and the emulsification reaction was stirred at a speed of 10,000 rpm for 15 minutes. After the emulsification was completed, the mixture was ultrasonically treated at 200 W for 10 minutes to obtain a nanoemulsion; (3): the nanoemulsion prepared in step (2) is placed at 4° C. for 12 h, subjected to refrigerated centrifugation at 3000 rpm for 10 min, and filtered through a 0.22 μm filter membrane to obtain a nano-essential oil emulsion; S8: Preparation of the tranquilizing and soothing composition for assisting the treatment of heart disease: 1: Disperse modified hydroxypropyl methylcellulose in 15 parts by weight of deionized water, heat in a water bath to 60°C, stir and dissolve evenly to obtain a modified hydroxypropyl methylcellulose solution; melt polyurethane at 80°C, then add it to the modified hydroxypropyl methylcellulose solution, stir and mix evenly, then melt polyethylene at 80°C and add it, continue to stir and mix evenly to obtain a mixed solution; 2: Dissolve polymethacrylate in 10 times the weight of 60wt% ethanol solution, stir and mix evenly to obtain a polymethacrylate solution; add the polymethacrylate solution to the mixed solution prepared in step 1, heat to 60°C in a water bath, stir for 30 minutes, mix evenly, add the nano essential oil emulsion, keep the temperature at 40°C, stir and mix evenly, pour it into a mold, the thickness parameter is 0.1mm, dry at room temperature for 2h, raise the temperature to 35°C, dry for 24h, and obtain a matrix layer; 3: Add the Platycladus orientalis seed extract, Ziziphus jujuba seed extract, Polygala tenuifolia extract and Acorus calamus extract in the drug layer to 8 parts by weight of 70wt% ethanol solution, stir and dissolve evenly to obtain an extract solution; 4: Scrape the extract solution prepared in step 3 onto the matrix layer prepared in step 2, with a thickness of 20 μm each time, and apply 3 times. Dry at 30°C for 10 minutes after each application. After all the application is completed, dry at 40°C for 60 minutes to obtain a tranquilizing and calming composition.
[0028] Example 2: A tranquilizing and calming composition for assisting the treatment of heart disease, comprising the following raw materials: 60 parts of a drug layer, 30 parts of polyurethane, 45 parts of modified hydroxypropyl methylcellulose, 30 parts of polyethylene, 22 parts of polymethacrylate, 9 parts of glycerol and 10 parts of a permeation enhancer; The drug layer composition includes the following raw materials: 15 parts of Semen Platycladi Extract, 25 parts of Semen Ziziphi Spinosae Extract, 10 parts of Polygala Tenuifolia Extract, 10 parts of Acorus Tatarinowii Extract and 20 parts of Chinese herbal medicine extract; The composition of the Chinese medicine extract includes the following raw materials by weight: 15 parts of Schisandra chinensis, 20 parts of Ziziphus jujuba seeds, 12 parts of white peony root, 15 parts of Chinese angelica root, 8 parts of Gardenia jasminoides, 12 parts of Pinellia tuber, 20 parts of Lotus core, 8 parts of Licorice, 10 parts of Poria cocos, 5 parts of Atractylodes macrocephala and 20 parts of Ophiopogon japonicus.
[0029] The specific preparation steps of the tranquilizing and calming composition for assisting the treatment of heart disease are as follows: S1: The cypress seed extract is prepared by ethanol reflux extraction using 80 wt % ethanol as solvent; S2: the spinosa jujube seed extract is prepared by ethanol reflux extraction using 40 wt % ethanol as solvent; S3: The polygala root extract is prepared by a water decoction method using water as a solvent; S4: The Acorus calamus extract is prepared by steam distillation using water as solvent; S5: The Chinese herbal medicine extract is prepared by water decoction using water as solvent; S6: The preparation steps of the modified hydroxypropyl methylcellulose are as follows: I: Add hydroxypropyl methylcellulose to anhydrous dichloromethane, heat in a water bath to 58°C, stir and dissolve evenly to obtain a 10wt% hydroxypropyl methylcellulose solution; II: Add 26 mL of hexadecyltrimethoxysilane to 200 mL of hydroxypropyl methylcellulose solution prepared in step I, continue stirring and heat to 95°C at a rate of 5°C / min. After heating, add 0.25 g of p-toluenesulfonic acid, maintain the temperature, stir and react for 6 hours, and cool to room temperature to obtain a mixed solution; III: Add 3.8 mL of 10 wt% sodium bicarbonate solution to the mixed solution prepared in step II, let stand for stratification, remove the upper organic phase, dry with anhydrous sodium sulfate, then filter to remove anhydrous sodium sulfate, wash with ethanol, and dry under vacuum at 50° C. to constant weight to obtain modified hydroxypropyl methylcellulose; S7: The penetration enhancer is a nano essential oil emulsion, and the specific preparation steps are as follows: (1): 20 mL of lavender oil, 20 mL of thyme oil, 20 mL of ylang-ylang oil and 40 mL of sweet almond oil were mixed, 5 g of Tween-80 and 5 mL of propylene glycol were added, the mixture was heated in a water bath to control the temperature at 35°C, and stirred at 400 rpm for 40 min to obtain an oil phase; (2): 70 mL of anhydrous ethanol was added to 500 mL of deionized water, and the mixture was stirred to obtain an aqueous phase; 100 mL of the oil phase prepared in step (1) was slowly poured into 450 mL of the aqueous phase during stirring, and the treatment operation was carried out in an ice bath, while stirring the emulsification reaction at a speed of 12000 rpm for 15 minutes. After the emulsification was completed, the mixture was ultrasonically treated at 300 W for 6 minutes to obtain a nanoemulsion; (3): the nanoemulsion prepared in step (2) is placed at 4° C. for 12 h, subjected to refrigerated centrifugation at 3000 rpm for 10 min, and filtered through a 0.22 μm filter membrane to obtain a nano-essential oil emulsion; S8: Preparation of the tranquilizing and soothing composition: 1: Disperse modified hydroxypropyl methylcellulose in 15 parts by weight of deionized water, heat in a water bath to 65°C, stir and dissolve evenly to obtain a modified hydroxypropyl methylcellulose solution; melt polyurethane at 80°C, then add it to the modified hydroxypropyl methylcellulose solution, stir and mix evenly, then melt polyethylene at 80°C and add it, continue to stir and mix evenly to obtain a mixed solution; 2: Dissolve polymethacrylate in 10 times the weight of 60wt% ethanol solution, stir and mix evenly to obtain a polymethacrylate solution; add the polymethacrylate solution to the mixed solution prepared in step 1, heat to 60°C in a water bath, stir for 30 minutes, mix evenly, add the nano essential oil emulsion, maintain the temperature at 40°C, stir and mix evenly, pour it into a mold, the thickness parameter is 0.3mm, dry at room temperature for 4h, raise the temperature to 35°C, dry for 24h, and obtain a matrix layer; 3: Add the Platycladus orientalis seed extract, Ziziphus jujuba seed extract, Polygala tenuifolia extract and Acorus calamus extract in the drug layer to 8 parts by weight of 70wt% ethanol solution, stir and dissolve evenly to obtain an extract solution; 4: Scrape the extract solution prepared in step 3 onto the matrix layer prepared in step 2, with a thickness of 50 μm each time, and apply 3 times. Dry at 40°C for 10 minutes after each application. After all the application is completed, dry at 40°C for 60 minutes to obtain a tranquilizing and calming composition.
[0030] Example 3: A tranquilizing and calming composition for assisting the treatment of heart disease, comprising the following raw materials: 50 parts of a drug layer, 30 parts of polyurethane, 40 parts of modified hydroxypropyl methylcellulose, 28 parts of polyethylene, 20 parts of polymethacrylate, 8 parts of glycerol and 9 parts of a permeation enhancer; The drug layer comprises the following raw materials: 15 parts of Semen Platycladi Extract, 20 parts of Semen Ziziphi Spinosae Extract, 7 parts of Polygala Tenuifolia Extract, 8 parts of Acorus Tatarinowii Extract and 18 parts of Chinese herbal medicine extract.
[0031] The composition of the Chinese medicine extract includes the following raw materials by weight: 12 parts of Schisandra chinensis, 18 parts of Ziziphus jujuba seeds, 14 parts of white peony root, 12 parts of Angelica sinensis, 8 parts of Gardenia jasminoides, 14 parts of Pinellia tuber, 18 parts of Lotus pith, 8 parts of Licorice, 8 parts of Poria cocos, 4 parts of Atractylodes macrocephala and 18 parts of Ophiopogon japonicus.
[0032] The specific preparation steps of the tranquilizing and calming composition for assisting the treatment of heart disease are as follows: S1: The cypress seed extract is prepared by ethanol reflux extraction using 80 wt % ethanol as solvent; S2: the spinosa jujube seed extract is prepared by ethanol reflux extraction using 40 wt % ethanol as solvent; S3: The polygala root extract is prepared by a water decoction method using water as a solvent; S4: The Acorus calamus extract is prepared by steam distillation using water as solvent; S5: The Chinese herbal medicine extract is prepared by water decoction using water as solvent; S6: The preparation steps of the modified hydroxypropyl methylcellulose are as follows: I: Add hydroxypropyl methylcellulose to anhydrous dichloromethane, heat in a water bath to 55°C, stir and dissolve evenly to obtain an 8wt% hydroxypropyl methylcellulose solution; II: Add 24 mL of hexadecyltrimethoxysilane to 250 mL of hydroxypropyl methylcellulose solution prepared in step I, continue stirring and heat to 90°C at a rate of 4°C / min. After heating, add 0.25 g of p-toluenesulfonic acid, maintain the temperature, stir and react for 6 hours, and cool to room temperature to obtain a mixed solution; III: Add 3.2 mL of 10 wt% sodium bicarbonate solution to the mixed solution prepared in step II, let stand for stratification, remove the upper organic phase, dry with anhydrous sodium sulfate, then filter to remove anhydrous sodium sulfate, wash with ethanol, and dry under vacuum at 50° C. to constant weight to obtain modified hydroxypropyl methylcellulose; S7: The penetration enhancer is a nano essential oil emulsion, and the specific preparation steps are as follows: (1): 20 mL of lavender oil, 20 mL of thyme oil, 20 mL of ylang-ylang oil and 40 mL of sweet almond oil were mixed, 4 g of Tween-80 and 4 mL of propylene glycol were added, the mixture was heated in a water bath to control the temperature at 35°C, and stirred at 500 rpm for 40 min to obtain an oil phase; (2): 65 mL of anhydrous ethanol was added to 500 mL of deionized water, and the mixture was stirred to obtain an aqueous phase; 100 mL of the oil phase prepared in step (1) was slowly poured into 400 mL of the aqueous phase during the stirring process, and the treatment operation was carried out in an ice bath, and the emulsification reaction was stirred at a speed of 14000 rpm for 10 minutes. After the emulsification was completed, the mixture was ultrasonically treated at 300 W for 10 minutes to obtain a nanoemulsion; (3): the nanoemulsion prepared in step (2) is placed at 4° C. for 12 h, subjected to refrigerated centrifugation at 3000 rpm for 10 min, and filtered through a 0.22 μm filter membrane to obtain a nano-essential oil emulsion; S8: Preparation of the tranquilizing and soothing composition: 1: Disperse modified hydroxypropyl methylcellulose in 15 parts by weight of deionized water, heat in a water bath to 65°C, stir and dissolve evenly to obtain a modified hydroxypropyl methylcellulose solution; melt polyurethane at 80°C, then add it to the modified hydroxypropyl methylcellulose solution, stir and mix evenly, then melt polyethylene at 85°C and add it, continue to stir and mix evenly to obtain a mixed solution; 2: Dissolve polymethacrylate in 10 times the weight of 60wt% ethanol solution, stir and mix evenly to obtain a polymethacrylate solution; add the polymethacrylate solution to the mixed solution prepared in step 1, heat to 60°C in a water bath, stir for 30 minutes, mix evenly, add the nano essential oil emulsion, keep the temperature at 40°C, stir and mix evenly, pour it into a mold, the thickness parameter is 0.2mm, dry at room temperature for 3h, raise the temperature to 40°C, dry for 18h, and obtain a matrix layer; 3: Add the Platycladus orientalis seed extract, Ziziphus jujuba seed extract, Polygala tenuifolia extract and Acorus calamus extract in the drug layer to 8 parts by weight of 70wt% ethanol solution, stir and dissolve evenly to obtain an extract solution; 4: Scrape the extract solution prepared in step 3 onto the matrix layer prepared in step 2, with a thickness of 40 μm each time, and apply 3 times. Dry at 35°C for 10 minutes after each application. After all the application is completed, dry at 40°C for 60 minutes to obtain a tranquilizing and calming composition.
[0033] Example 4: A tranquilizing and calming composition for assisting the treatment of heart disease, comprising the following raw materials: 60 parts of a drug layer, 35 parts of polyurethane, 50 parts of modified hydroxypropyl methylcellulose, 35 parts of polyethylene, 25 parts of polymethacrylate, 10 parts of glycerol and 12 parts of a penetration enhancer; The drug layer comprises the following raw materials: 15 parts of Semen Platycladi Extract, 25 parts of Semen Ziziphi Spinosae Extract, 10 parts of Polygala Tenuifolia Extract, 10 parts of Acorus Tatarinowii Extract and 20 parts of Chinese herbal medicine extract.
[0034] The composition of the Chinese medicine extract includes the following raw materials in parts by weight: 15 parts of Schisandra chinensis, 20 parts of Ziziphus jujuba seeds, 15 parts of white peony root, 15 parts of Chinese angelica root, 10 parts of Gardenia jasminoides, 15 parts of Pinellia tuber, 20 parts of Lotus core, 10 parts of Licorice, 10 parts of Poria cocos, 5 parts of Atractylodes macrocephala and 20 parts of Ophiopogon japonicus.
[0035] The specific preparation steps of the tranquilizing and calming composition for assisting the treatment of heart disease are as follows: S1: The cypress seed extract is prepared by ethanol reflux extraction using 80 wt % ethanol as solvent; S2: the spinosa jujube seed extract is prepared by ethanol reflux extraction using 40 wt % ethanol as solvent; S3: The polygala root extract is prepared by a water decoction method using water as a solvent; S4: The Acorus calamus extract is prepared by steam distillation using water as solvent; S5: The Chinese herbal medicine extract is prepared by water decoction using water as solvent; S6: The preparation steps of the modified hydroxypropyl methylcellulose are as follows: I: Add hydroxypropyl methylcellulose to anhydrous dichloromethane, heat in a water bath to 60°C, stir and dissolve evenly to obtain a 10 wt% hydroxypropyl methylcellulose solution; II: Add 30 mL of hexadecyltrimethoxysilane to 200 mL of hydroxypropyl methylcellulose solution prepared in step I, continue stirring and heat to 100°C at a rate of 5°C / min. After heating, add 0.3 g of p-toluenesulfonic acid, maintain the temperature, stir and react for 4 hours, and cool to room temperature to obtain a mixed solution; III: Add 5.4 mL of 10 wt% sodium bicarbonate solution to the mixed solution prepared in step II, let stand for stratification, remove the upper organic phase, dry with anhydrous sodium sulfate, then filter to remove anhydrous sodium sulfate, wash with ethanol, and dry under vacuum at 50° C. to constant weight to obtain modified hydroxypropyl methylcellulose; S7: The penetration enhancer is a nano essential oil emulsion, and the specific preparation steps are as follows: (1): 20 mL of lavender oil, 20 mL of thyme oil, 20 mL of ylang-ylang oil and 40 mL of sweet almond oil were mixed, 5 g of Tween-80 and 5 mL of propylene glycol were added, the mixture was heated in a water bath to control the temperature at 35°C, and stirred at 500 rpm for 30 min to obtain an oil phase; (2): 75 mL of anhydrous ethanol was added to 500 mL of deionized water, and the mixture was stirred to obtain an aqueous phase; 100 mL of the oil phase prepared in step (1) was slowly poured into the 500 mL of aqueous phase during the stirring process, and the treatment operation was carried out in an ice bath, and the emulsification reaction was stirred at a speed of 15000 rpm for 10 minutes. After the emulsification was completed, the mixture was ultrasonically treated at 400 W for 5 minutes to obtain a nanoemulsion; (3): the nanoemulsion prepared in step (2) is placed at 4° C. for 12 h, subjected to refrigerated centrifugation at 3000 rpm for 10 min, and filtered through a 0.22 μm filter membrane to obtain a nano-essential oil emulsion; S8: Preparation of the tranquilizing and soothing composition: 1: Disperse modified hydroxypropyl methylcellulose in 15 parts by weight of deionized water, heat in a water bath to 70°C, stir and dissolve evenly to obtain a modified hydroxypropyl methylcellulose solution; melt polyurethane at 80°C, then add it to the modified hydroxypropyl methylcellulose solution, stir and mix evenly, then melt polyethylene at 90°C and add it, continue to stir and mix evenly to obtain a mixed solution; 2: Dissolve polymethacrylate in 10 times the weight of 60wt% ethanol solution, stir and mix evenly to obtain a polymethacrylate solution; add the polymethacrylate solution to the mixed solution prepared in step 1, heat to 60°C in a water bath, stir for 30 minutes, mix evenly, add the nano essential oil emulsion, keep the temperature at 40°C, stir and mix evenly, pour it into a mold, the thickness parameter is 0.3mm, dry at room temperature for 4h, raise the temperature to 45°C, dry for 12h, and obtain a matrix layer; 3: Add the Platycladus orientalis seed extract, Ziziphus jujuba seed extract, Polygala tenuifolia extract and Acorus calamus extract in the drug layer to 8 parts by weight of 70wt% ethanol solution, stir and dissolve evenly to obtain an extract solution; 4: Scrape the extract solution prepared in step 3 onto the matrix layer prepared in step 2, with a thickness of 50 μm each time, and apply 3 times. Dry at 40°C for 10 minutes after each application. After all the application is completed, dry at 40°C for 60 minutes to obtain a tranquilizing and calming composition.
[0036] Comparative Example 1: The operation of Comparative Example 1 is basically the same as that of Example 2, except that propylene glycol is used to replace the nano essential oil emulsion in Comparative Example 1. Comparative Example 2: The operation of Comparative Example 2 is basically the same as that of Example 2, except that the drug layer in Comparative Example 2 lacks the extract of Ziziphus jujuba seed and the extract of Platycladus orientalis seed.
[0037] Comparative Example 3: The operation of Comparative Example 3 is substantially the same as that of Example 3, except that hydroxypropyl methylcellulose is used in Comparative Example 3 instead of modified hydroxypropyl methylcellulose.
[0038] Performance Test: Hydrophobicity test: The modified hydroxypropyl methylcellulose prepared in Examples 2 to 3 above and the control group (hydroxypropyl methylcellulose) were tested for contact angle. The larger the contact angle, the better the hydrophobic effect. The contact angle greater than 140° was recorded as A, the contact angle between 120° and 140° was recorded as B, the contact angle between 90° and 120° was recorded as C, and the contact angle below 90° was recorded as D. All samples were tested at room temperature and 50% humidity. 5 microliters of water droplets were used for each test. To ensure data reliability, 5 contact angle measurements were performed for each sample, and the average value was taken as the final result. The test results are shown in Table 1.
[0039] Table 1. Hydrophobicity test results.
[0040]
[0041] It can be seen from the results in Table 1 that the modified hydroxypropyl methylcellulose prepared in the present invention is successfully modified and its hydrophobicity is significantly enhanced.
[0042] Permeability test: Skin tissue taken from fresh pig ears was thoroughly washed with deionized water and cut into 2.5 cm 2The size of the sample was then soaked in a phosphate buffer for 30 minutes. The treated skin sample was sandwiched between the test pool and the test pool of the Franz diffusion cell to ensure that the keratin layer of the skin was facing upward. The tranquilizing and calming compositions prepared in Examples 2 to 3 and Comparative Examples 1 to 3 were applied to the inner side of the test pool to evenly cover the skin surface. Phosphate buffer was injected into the test pool as a receiving solution, and a stirrer was added. The Franz diffusion cell was adjusted to maintain a constant temperature of 37° C. The stirrer was started and stirred slowly. Every 1 hour, 1 mL of the receiving solution sample was taken out from the test pool. An equal amount of phosphate buffer was immediately added after sampling to keep the liquid level constant. The test was conducted for a total of 24 hours. The results are as follows Figure 1 shown.
[0043] Depend on Figure 1 As can be seen from the results, the tranquilizing and calming composition prepared by the present invention can be effectively released for a long time, and the release rate is uniform, and there will be no excessive release rate resulting in excessive local active ingredients, which in turn causes skin irritation. From the results of Comparative Example 1 and Example 2, it can be seen that due to the lack of nano-essential oil emulsion, the permeability of essential oils and fat-soluble drugs is significantly reduced. Without the nano-essential oil emulsion, the active ingredients cannot effectively penetrate into the deep layers of the skin, resulting in a low drug concentration in the test pool; from the results of Comparative Example 2 and Example 2, it can be seen that in the early stage of the test, the penetration rate is relatively slow and unstable, the increase in drug concentration in the test pool is not obvious, and the dissolution rate is not significantly increased. Very low, which may be due to the lack of cypress seed extract, which reduces the diffusion depth of fat-soluble components in the skin, resulting in a lower drug concentration in the test pool; from the results of Comparative Example 3 and Example 3, it can be seen that the total permeation within 24 hours is low, and the permeation rate curve shows a trend of rapid decline in the permeation rate after early rapid release. This may be because the role of modified hydroxypropyl methylcellulose is to improve the stability and permeability of the drug, especially the coating and release control of fat-soluble drugs. Unmodified hydroxypropyl methylcellulose is used in Comparative Example 2, which shortens the residence time of the drug on the skin surface, thereby making the drug release unstable.
[0044] Sleep extension test in mice: Healthy adult mice weighing between 18 and 22 grams were selected and randomly divided into two groups: a control group and an experimental group, with 14 mice in each group. The mice in the experimental group were treated with the patch before the experiment (1 cm prepared in Examples 1 to 4 and Comparative Examples 1 to 3). 2The patch was fixed on the abdominal skin of the experimental group mice by patching, ensuring that the patch was in close contact with the skin for at least 4 hours to ensure the absorption of the drug components. The control group was not treated with any patch and maintained in a normal state. After the patch treatment, all mice (including the control group and the experimental group) were intraperitoneally injected with sodium pentobarbital (40 mg / kg) to induce the mice to sleep. After the injection, the mice were immediately placed in a separate observation cage to observe and record the duration of the mice's sleep, that is, the time from the loss of the righting reflex to the recovery of the righting reflex. This period of time was the sleep time of the mice. The statistical results are as follows Figure 2 shown.
[0045] Depend on Figure 2 As can be seen from the results, the tranquilizing and analgesic composition prepared by the present invention can effectively promote the sleep time of mice, which has an excellent effect on tranquilizing the mind; from the results of Comparative Example 1 and Example 2, it can be seen that the use of propylene glycol instead of the nano essential oil emulsion exhibits a shorter sleep duration, which may be due to the fact that the effect of the nano essential oil emulsion in enhancing transdermal absorption cannot be replaced by propylene glycol, resulting in a decrease in the absorption efficiency of drug ingredients, especially essential oil substances; from the results of Comparative Example 2 and Example 2, it can be seen that the extracts of Ziziphus jujuba and Platycladus cypress have sedative and tranquilizing effects, and their absence will significantly affect the overall synergistic therapeutic effect of the patch, and its sleep time is significantly close to that of the control group; from the results of Comparative Example 3 and Example 3, it can be seen that Comparative Example 3 exhibits a lower sleep time than Example 3, which may be due to the use of hydroxypropyl methylcellulose instead of modified hydroxypropyl methylcellulose to reduce the absorption efficiency of fat-soluble drugs and essential oils in the patch, resulting in uneven drug release or incomplete absorption.
[0046] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A calming and tranquilizing composition for assisting the treatment of heart disease, It is characterized in that The composition includes the following raw materials: 40 to 60 parts of drug layer, 25 to 35 parts of polyurethane, 35 to 50 parts of modified hydroxypropyl methylcellulose, 20 to 35 parts of polyethylene, 15 to 25 parts of polymethacrylate, 5 to 10 parts of glycerol and 7 to 12 parts of penetration enhancer; The drug layer comprises the following raw materials: 12 to 15 parts of cypress seed extract, 18 to 25 parts of spiny jujube seed extract, 4 to 10 parts of polygala root extract, 6 to 10 parts of calamus tatarinowii extract and 15 to 20 parts of traditional Chinese medicine extract; The composition of the Chinese medicine extract includes the following raw materials by weight: 10-15 parts of Schisandra chinensis, 15-20 parts of Ziziphus jujuba seeds, 10-15 parts of white peony root, 10-15 parts of Chinese angelica root, 5-10 parts of Gardenia jasminoides, 10-15 parts of Pinellia tuber, 15-20 parts of Lotus pith, 5-10 parts of Licorice root, 5-10 parts of Poria cocos, 3-5 parts of Atractylodes macrocephala, and 15-20 parts of Ophiopogon japonicus; The traditional Chinese medicine extract is prepared by a water decoction method using water as a solvent.
2. A tranquilizing and calming composition for assisting the treatment of heart disease according to claim 1, It is characterized in that The preparation steps of the modified hydroxypropyl methylcellulose are as follows: I: Add hydroxypropyl methylcellulose to anhydrous dichloromethane, heat in a water bath, stir and dissolve evenly to obtain a hydroxypropyl methylcellulose solution; II: adding hexadecyltrimethoxysilane to the hydroxypropyl methylcellulose solution prepared in step I, stirring continuously and heating to 80-100° C. at a rate of 2-5° C. / min. After heating, adding p-toluenesulfonic acid, maintaining the temperature, stirring the reaction, and cooling to room temperature to obtain a mixed solution; III: Add sodium bicarbonate solution to the mixed solution prepared in step II, let stand to separate the layers, remove the upper organic phase, dry with anhydrous sodium sulfate, then filter to remove the anhydrous sodium sulfate, wash with ethanol, and vacuum dry to constant weight to obtain modified hydroxypropyl methylcellulose.
3. A tranquilizing and calming composition for assisting the treatment of heart disease according to claim 2, It is characterized in that In step II, the ratio of hexadecyltrimethoxysilane to hydroxypropylmethylcellulose is 0.8-1.5 mL:1 g; the ratio of p-toluenesulfonic acid to hexadecyltrimethoxysilane is 0.005-0.01 g:1 mL.
4. A tranquilizing and calming composition for assisting the treatment of heart disease according to claim 3, It is characterized in that The ratio of the sodium bicarbonate solution to the p-toluenesulfonic acid in step III is 13-18 mL: 1 g.
5. A tranquilizing and calming composition for assisting the treatment of heart disease according to claim 4, It is characterized in that The penetration enhancer is a nano essential oil emulsion, and the specific preparation steps are as follows: (1): lavender oil, thyme oil, ylang-ylang oil and sweet almond oil are mixed in a volume ratio of 1:1:1:2, Tween-80 and propylene glycol are added, the temperature is controlled by heating in a water bath, and the mixture is stirred and mixed to obtain an oil phase; (2): adding anhydrous ethanol to deionized water, stirring and mixing to obtain an aqueous phase; pouring the oil phase prepared in step (1) into the aqueous phase slowly and continuously during the stirring process, stirring at a high speed for emulsification reaction, and after the emulsification is completed, ultrasonic treatment is performed to obtain a nanoemulsion; (3): The nanoemulsion prepared in step (2) is allowed to stand at 4°C, subjected to refrigerated centrifugation, and filtered through a filter membrane to obtain a nano-essential oil emulsion.
6. A tranquilizing and calming composition for assisting the treatment of heart disease according to claim 5, It is characterized in that The lavender oil, thyme oil and ylang ylang oil in step (1) are prepared by steam distillation; and the sweet almond oil is prepared by cold pressing.
7. A tranquilizing and calming composition for assisting the treatment of heart disease according to claim 6, It is characterized in that In step (2), the amount of anhydrous ethanol used is 10-15% of the volume of deionized water, and the amount of water phase used is 3-5 times the volume of the oil phase; the emulsification stirring operation and ultrasonic treatment operation are both carried out in an ice bath.
8. A method for preparing the tranquilizing and calming composition for assisting the treatment of heart disease according to any one of claims 1 to 7, It is characterized in that The specific preparation steps are as follows: 1: Disperse the modified hydroxypropyl methylcellulose in 15 parts by weight of deionized water, heat in a water bath to control the temperature, stir and dissolve evenly to obtain a modified hydroxypropyl methylcellulose solution; melt the polyurethane, then add it to the modified hydroxypropyl methylcellulose solution, stir and mix evenly, then melt the polyethylene and add it, continue to stir and mix evenly to obtain a mixed solution; 2: dissolving polymethacrylate in 10 parts by weight of ethanol solution, stirring and mixing evenly to obtain a polymethacrylate solution; adding the polymethacrylate solution to the mixed solution prepared in step 1, heating in a water bath to control the temperature, stirring, mixing evenly, adding the nano essential oil emulsion, maintaining the temperature, stirring and mixing evenly, and pouring it into a mold, with a thickness parameter of 0.1 to 0.3 mm, drying at room temperature, raising the temperature, and continuing to dry to obtain a matrix layer; 3: Add the Platycladus orientalis seed extract, Ziziphus jujuba seed extract, Polygala tenuifolia extract, Acorus calamus extract and Chinese herbal medicine extract in the drug layer to 8 parts by weight of the ethanol solution, stir and dissolve evenly to obtain an extract solution; 4: Scrape the extract solution prepared in step 3 onto the matrix layer prepared in step 2, with a thickness of 20 to 50 μm each time, and apply three times. Dry at 30 to 40° C. for 10 min after each application. After all the application is completed, dry to obtain a tranquilizing and calming composition.
